{"id":"haart-containing-nevirapine","safety":{"commonSideEffects":[{"rate":"10%","effect":"Rash"},{"rate":"20%","effect":"Nausea"},{"rate":"15%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL57","moleculeType":"Small molecule","molecularWeight":"266.30"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Nevirapine works by inhibiting the activity of reverse transcriptase, an enzyme that HIV uses to replicate its genetic material.","oneSentence":"Non-nucleoside reverse transcriptase inhibitor","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:40:27.246Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV-1 infection"}]},"trialDetails":[{"nctId":"NCT00476853","phase":"PHASE2","title":"Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy","status":"COMPLETED","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"2005-10","conditions":"HIV Infections, Tuberculosis","enrollment":42},{"nctId":"NCT00427297","phase":"PHASE3","title":"Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya","status":"TERMINATED","sponsor":"University of Washington","startDate":"2007-09","conditions":"HIV Infections","enrollment":34},{"nctId":"NCT00624195","phase":"PHASE2, PHASE3","title":"Clinical Trial of CNS-targeted HAART (CIT2)","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2007-03","conditions":"HIV Infections","enrollment":59}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"HAART containing nevirapine","genericName":"HAART containing nevirapine","companyName":"The HIV Netherlands Australia Thailand Research Collaboration","companyId":"the-hiv-netherlands-australia-thailand-research-collaboration","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Non-nucleoside reverse transcriptase inhibitor Used for HIV-1 infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}